Author

Tanja Kierschniak

Observed institution: Pharmacyclics (United States)

OpenAlex ID: A5072539751

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

2014 · Jacqueline C. Barrientos, Susan O'Brien, et al. · Blood · 16

Haematologic and immunologic function and patient-reported outcomes for the phase 3 RESONATE (TM) study of ibrutinib versus ofatumumab in relapsed/refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma

2015 · Talha Munir, Jacqueline C. Barrientos, et al. · British Journal of Haematology · 1

Works count: 2

Citation count: 17

H-index: 1

I10-index: 1